25
Venus Medtech (Hangzhou) Inc.
2500.HK · HKSE
$1.10 -4.35% (-$0.05)
1M +6.48%
Market Cap ¥437.5M
P/E Ratio -
Div. Yield -
ROE 21.55%
Piotroski F-Score Weak
3/9Valuation
97 /100
Cheap P/B 0.25x
P/S 1.43x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 21.23%
Rev. growth 8.95%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 112.56%
Gross margin 69.05%
FCF margin 108.26%
Quality
2 /100
Poor ROA 16.17%
ROIC 14.98%
Asset turnover 0.12x
Debt
69 /100
Low Int. coverage -19.39x
Debt/Equity 0.12x
Current ratio 2.77x
Stability
52 /100
Moderate EPS volatility 23.26%
Beta 1.16x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 2500.HK
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Hou-Sen Lim
Employees
557
Headquarters
Hangzhou
Evenimente viitoare
01 APR.
Earnings
Upcoming earnings report